NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Nutex Health Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$191.25+5.15 (+2.77%)
Close on Oct 19, 2026
- Market cap
- $1.34B
- P/E (TTM)
- 7.5
- Dividend yield
- –
Share price
+$96.42 (+101.7%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
Nutex Health Inc. grew revenue 6.9% to $846.72M over the twelve months to Jun 30, 2026. Operating income rose 52.9% to $364.27M, moving the operating margin from 30.1% to 43.0%. Free cash flow was $274.17M, up 229.4% from a year earlier.
Revenue
$846.72M
+6.9% vs. a year earlier
Operating income
$364.27M
+52.9% vs. a year earlier
Free cash flow
$274.17M
+229.4% vs. a year earlier
EPS, diluted
$25.40
+159.7% vs. a year earlier
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.34B
- P/E ratio
- 7.5
- Price to sales
- 1.59
- Price to book
- 3.41
- Dividend yield
- –
- Free cash flow yield
- 20.42%
Fundamentals
- Revenue
- $846.72M
- Net income
- $179.92M
- EPS, diluted
- $25.40
- Free cash flow
- $274.17M
- Book value per share
- $56.16
- Diluted shares
- 7M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$846.72M+6.9% YoY
Gross profit
$434.03M+6.7% YoY
Operating income
$364.27M+52.9% YoY
Net income
$179.92M+218.8% YoY
EPS, diluted
$25.40+159.7% YoY
Free cash flow
$274.17M+229.4% YoY
Reported periodTrailing twelve months